What is the recommended first-line treatment for scabies, including dosing and special population considerations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

First-Line Treatment for Scabies

Permethrin 5% cream applied to all areas of the body from the neck down and washed off after 8-14 hours is the recommended first-line treatment for scabies. 1

Standard Dosing and Application

For typical scabies:

  • Permethrin 5% cream: Apply from neck down to entire body, leave on for 8-14 hours, then wash off 1
  • This is effective, safe, and less expensive than ivermectin 1

Alternative first-line option:

  • Oral ivermectin 200 μg/kg, repeated in 2 weeks 1
  • Must be taken with food to increase bioavailability and epidermal penetration 1
  • The second dose at 14 days is essential because ivermectin has limited ovicidal activity 1

Special Population Considerations

Infants and Young Children

  • Use permethrin 5% cream - this is the preferred agent 1
  • Permethrin appears safe even in children <2 months of age 2
  • Never use lindane in children <10 years 1

Pregnant and Lactating Women

  • Permethrin 5% cream is safe and can be used during pregnancy and lactation 1, 2
  • Ivermectin is classified as "human data suggest low risk" in pregnancy and probably compatible with breastfeeding 1
  • Avoid lindane - associated with neural tube defects and mental retardation, accumulates in placenta and breast milk 1

Elderly and Debilitated Patients

  • Use permethrin 5% cream as first choice 1
  • One study showed increased mortality in elderly, debilitated persons receiving ivermectin, though not confirmed in subsequent reports 1
  • Exercise caution with ivermectin in this population

Immunocompromised Patients (HIV, Organ Transplant, etc.)

  • Same treatment regimen as immunocompetent patients for uncomplicated scabies 1
  • Higher risk for crusted scabies - requires different approach (see below)

Patients with Renal or Liver Disease

  • Ivermectin dosing adjustments not required for renal impairment 1
  • Safety of multiple ivermectin doses unknown in severe liver disease 1

Crusted (Norwegian) Scabies

Combination therapy is mandatory:

  • Topical permethrin 5% cream: Full-body application daily for 7 days, then twice weekly until cure 1
  • PLUS oral ivermectin 200 μg/kg on days 1,2,8,9, and 15 1
  • Additional ivermectin on days 22 and 29 may be needed for severe cases 1
  • Never use lindane - risk of neurotoxicity with heavy applications or denuded skin 1

Alternative Regimens (Second-Line)

Lindane 1% (1 oz lotion or 30 g cream):

  • Apply thin layer from neck down, wash off after 8 hours 1
  • Only use if patient cannot tolerate recommended therapies or if they have failed 1
  • Risk of seizures and aplastic anemia 1
  • Resistance reported in some U.S. areas 1

Contraindications for lindane:

  • Children <10 years 1
  • Pregnant or lactating women 1
  • Extensive dermatitis 1
  • Never apply immediately after bath/shower 1

Essential Adjunctive Measures

Environmental decontamination:

  • Machine-wash and machine-dry bedding/clothing using hot cycle, OR dry clean, OR remove from body contact for at least 72 hours 1
  • Fumigation of living areas is unnecessary 1

Patient counseling:

  • Keep fingernails closely trimmed to reduce scratching injury 1
  • Pruritus may persist up to 2 weeks after successful treatment 1

Follow-Up Protocol

Timing: Evaluate at 2 weeks and 4 weeks 3

Treatment failure indicators (symptoms >2 weeks):

  • Live mites or burrows detected 1
  • New clinical lesions developing 1
  • Worsening pruritus 1

Common causes of persistent symptoms:

  • Medication resistance or faulty application 1
  • Reinfection from untreated family members or fomites 1
  • Cross-reactivity with other household mites 1
  • Allergic dermatitis (can worsen even with successful treatment) 1

Management of persistent symptoms:

  • Consider retreatment at 2 weeks if symptomatic or live mites observed 1
  • Use alternative regimen if no response to initial treatment 1

Contact Management

All sexual and close personal/household contacts within the preceding month must be examined and treated 1, even if asymptomatic in high-risk situations 3

Sexual contact should be avoided until patients and partners complete treatment 1

Common Pitfalls to Avoid

  1. Incomplete application: Permethrin must cover entire body from neck down - missing areas leads to treatment failure
  2. Single-dose ivermectin: Always give second dose at 14 days due to limited ovicidal activity 1
  3. Premature retreatment: Persistent itch for up to 2 weeks is normal, not treatment failure 1
  4. Neglecting contacts: Failure to treat close contacts leads to reinfection 1
  5. Using lindane as first-line: Reserve for treatment failures only due to toxicity risk 1

Related Questions

What is the recommended treatment for scabies?
What isolation precautions and treatment are recommended for a patient with scabies?
My asymptomatic relative was exposed to scabies; which ICD‑10 codes should be used for the exposure and for confirmed scabies infection?
What is the appropriate treatment for scabies in a 3½‑year‑old girl?
In a skilled nursing facility, two residents present with pruritus and scaling lesions on the dorsal forearms, anterior thighs, lower legs (both anterior and posterior), and one also has facial and upper chest scaling, with no involvement of nipples, axillae, belt line, genitalia, hands, or fingers; what is the most appropriate management for suspected scabies?
Can propranolol be used as first‑line treatment for akathisia, and what are the recommended dosing guidelines and contraindications?
How should telmisartan be initiated, dosed, and monitored in patients with impaired renal function, and what are suitable alternative angiotensin receptor blockers if it is not tolerated?
What is the appropriate evaluation and management for a patient with 2 days of diarrhea accompanied by fever and arthralgia?
What is the best next step in treatment for a 45-year-old patient with three weeks of low back pain, a normal examination except for muscle spasm, and inadequate response to ibuprofen and massage?
What are the treatment options for a 77-year-old man with PSA 22 ng/mL, a current prostate biopsy showing Gleason 6 (3+3) cancer in 4 of 14 cores and focal high‑grade prostatic intra‑epithelial neoplasia (PIN) in 3 of 12 cores, and a prior biopsy showing Gleason 6 cancer in 2 of 12 cores?
What is the most likely cause of recurrent hyponatremia in this 56‑year‑old man with chronic alcohol use, type 2 diabetes mellitus, hypertension, and insomnia, who is taking gliclazide XR (Diamicron XR), metformin, metoprolol XL (Metolar XL), amlodipine, Spectra 75 (insomnia medication), lorazepam (Ativan), furosemide (DyTor), lactulose (Duphalac), and supplements (shilajit, giloy, ashwagandha, resveratrol), and has serum osmolality 272 mOsm/kg, urine osmolality 129 mOsm/kg, urine sodium 21 mmol/L, and serum sodium 134 mmol/L?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.